Caprion-HistoGeneX
is now CellCarta

Mapping Precision Medicine

Watch the video
Reveal Biosciences is now part of CellCarta

New generation of AI-Powered Pathology Solutions to enhance research, clinical trials, and improve patient outcomes globally

More details
Reveal Biosciences is now part of CellCarta
Our singular vision
has a bold, new name
Learn More
Our singular vision<br>has a bold, new name
Mosaic Laboratories is now part of CellCarta

Expanding our histological biomarker franchise to support global clinical trials

More details
Mosaic Laboratories is now part of CellCarta
Clinical Logistics Inc. is now part of CellCarta

Expanding our specimen logistics services to better support global clinical trials

More details
Clinical Logistics Inc. is now part of CellCarta
COVID-19 clinical testing for drug development

Your partner of choice to move your COVID-19 vaccine research forward and ensure business continuity

More details
COVID-19 clinical testing for drug development
Services
Technologies
Therapeutic Areas
Phases

Latest News and Events

CAR-TCR_ConferenceLogo

Event

CAR-TCR Summit

Virtual event

From August 30 2021 to September 2 2021

Book a meeting More info
CellCarta Logo

News

CellCarta acquires Reveal Biosciences

May 11, 2021

More info
CellCarta Logo

News

Caprion-HistoGeneX expands its histological biomarker franchise by joining forces with Mosaic Laboratories

January 12, 2021

More info
CellCarta Logo

News

Caprion-HistoGeneX acquires
Clinical Logistics Inc. - A virtual central specimen management CRO

January 7, 2021

More info
Services
CellEngineTM Software

Cytometry Analysis that is Faster, More Reliable with Advanced Visualization Features

More info
CellEngine<sup>TM</sup> Software
Services
Clinically Relevant Biomarkers in FFPE

Quantify Multiplex Biomarkers in FFPE Tissue Samples using MRM

More info
Clinically Relevant Biomarkers in FFPE
Therapeutic Area
Oncology

Developing and deploying assays for exploratory, secondary, and primary endpoints to support multitude of oncology programs.

More info
Oncology
Therapeutic Area
Infectious Diseases

From vaccine development to identification and validation of clinical biomarkers, CellCarta has the knowledge and technology to support the development of treatments for infectious diseases.

More info
Infectious Diseases

Science Hub

Posters

Quantification of sBCMA in Human Plasma using a High-Throughput Hybrid IP-MRM Based Mass Spectrometry Workflow

July 27, 2021

Proteomics/Mass Spectrometry

More info

Infographics

Wide Array of Services in Multiple Myeloma

June 21, 2021

More info

CellTalk

The Right Biomarker Strategy to Support Multiple Myeloma Emerging Therapies

June 9, 2021

More info

CellTalk

What steps to follow when developing multiplex IHC assays

May 26, 2021

More info

Careers

The best scientific minds working together to advance precision medicine

If you are passionate about science, join CellCarta and help shape the future of precision medicine.

See our job opportunities
Brandbourg_Caprion-1335-v2